Clinical Trials in Italy / NCT06793124
Recruiting
Observational
Comparison Diagnostic Tests for the Diagnosis of CYTOmegalovirus Organ Disease in Patients With intestinalBOweL Diseases
NCT06793124 · tracked via the Priya Life Science Italy tracker
Condition(s) studied
Cytomegalovirus (CMV)Inflammatory Bowel Disease (IBD)
Study summary
Observational, single-center, non-pharmacological, prospective study of adult patients affected by Inflammatory Bowel Disease (IBD) with an ongoing disease exacerbation requiring hospitalization
Eligibility
Inclusion Criteria:
* Patients aged ≥18 years with Inflammatory Bowel Disease (IBD) with worsening of IBD-related symptoms requiring hospital admission
* Signing of informed consent
* Performed endoscopic biopsies to confirm/exclude CMV organ disease
Exclusion Criteria: /
Primary outcome measure(s)
- Diagnostic Performance of CMV-DNA Quantification in Blood and Fecal Samples Compared to Immunohistochemistry on Biopsy for CMV Infection Diagnosis — Each samples taken from the patients will be tested through study completion (average of 2 year)
Evaluation of the diagnostic performance of different methods used for the diagnosis of CMV infection, i.e. CMV-DNA on blood and CMV-DNA on fecal samples - comparing them with the gold standard, i.e. immunohistochemical investigation on biopsy sample in patients affected by IBD with clinical worsening requiring hospitalization
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna | Bologna | Recruiting |
More IRCCS Azienda Ospedaliero-Universitaria di Bologna trials in Italy
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06793124 on ClinicalTrials.gov ↗ ← All trials in Italy